What is the likely diagnosis and appropriate management for a painful, raised, skin-colored lesion in the inguinal region without purulent drainage that does not appear to be a boil?

Likely Diagnosis and Management

The most likely diagnosis is early-stage hidradenitis suppurativa (HS), presenting as a painful inflammatory nodule in the groin, and you should initiate treatment with topical or oral antibiotics while referring to dermatology for definitive management and staging.

Clinical Reasoning

The presentation of a painful, raised, skin-colored lesion in the inguinal region without purulent drainage strongly suggests an early inflammatory nodule of hidradenitis suppurativa. HS characteristically presents with painful nodules, abscesses, and eventually sinus tracts in flexural areas including the groin, axillae, and perineum 1. The absence of purulent drainage and the skin-colored appearance indicate this is likely an early inflammatory phase before abscess formation or secondary infection develops 2.

Key Diagnostic Features to Confirm HS

The diagnosis requires 1:

• Typical lesions: Painful nodules (as in this case), abscesses, sinus tracts, bridged scars, or open comedones
• Typical sites: Groin, axillae, perineal/perianal regions, inframammary folds, or buttocks
• Chronicity and recurrence: The disease must be recurrent

Important caveat: HS is a clinical diagnosis and biopsy is rarely needed 1. However, if the lesion is atypical or solitary without recurrence, consider alternative diagnoses.

Alternative Diagnoses to Consider

While HS is most likely, maintain awareness of rarer possibilities:

• Dermoid cyst: Typically presents as an irreducible mass with gradual growth and local discomfort 3, but usually not acutely painful
• Sebaceous gland carcinoma: Extremely rare in the groin, presents as raised nodules with gradual growth over years 4, but typically not acutely painful
• Granuloma annulare: Can present in the inguinal region but typically shows annular erythematous plaques 5, not matching this description

Immediate Management Algorithm

1. Initial Assessment

• Examine for other flexural sites (axillae, submammary, buttocks) for additional lesions
• Ask about recurrent painful nodules or abscesses in these areas
• Assess family history (up to 42% have positive family history) 1
• Screen for associated conditions: smoking, diabetes, hypertension, depression 1

2. Staging and Severity

Use Hurley staging 1:

• Stage I: Isolated nodules/abscesses without sinus tracts or scarring (likely this case)
• Stage II: Recurrent abscesses with sinus tracts and scarring, separated lesions
• Stage III: Diffuse involvement with multiple interconnected sinus tracts

3. Treatment Based on Stage

For Stage I (Isolated Nodule - This Patient):

• Topical clindamycin 1% applied twice daily to affected areas
• Oral tetracycline antibiotics (doxycycline 100mg twice daily or minocycline 100mg twice daily) for anti-inflammatory effects
• Pain management: NSAIDs or acetaminophen as needed
• Lifestyle modifications: Weight loss if overweight, smoking cessation, avoid tight clothing 1

If progression or recurrence occurs:

• Refer to dermatology for consideration of systemic therapy
• Moderate-to-severe disease may require biologics (adalimumab or secukinumab/bimekizumab) 2

4. Red Flags Requiring Urgent Referral

• Rapid growth suggesting malignancy
• Systemic symptoms (fever, malaise)
• Fistula formation to urethra, bladder, or rectum 1
• Severe pain affecting quality of life
• Signs of squamous cell carcinoma in long-standing disease 1

Common Pitfalls to Avoid

• Don't dismiss as simple "boil": HS is often misdiagnosed, leading to delayed treatment and progression to irreversible scarring 2
• Don't use incision and drainage routinely: This can worsen scarring and is generally not recommended for HS nodules
• Don't prescribe prolonged high-potency topical corticosteroids: These can be deleterious in groin lesions 6
• Don't ignore psychological impact: HS has high rates of depression and suicide risk due to chronic pain, discharge, and malodor affecting intimate sites 1

Follow-Up Strategy

• Reassess in 2-4 weeks to evaluate treatment response
• If no improvement or worsening, refer to dermatology
• Long-term monitoring for cardiovascular disease, diabetes, and depression given strong associations 1
• Early aggressive treatment prevents irreversible skin damage with tunnel formation and scarring 2